Potential Drug Candidates to Treat TRPC6 Channel Deficiencies in the Pathophysiology of Alzheimer’s Disease and Brain Ischemia

Alzheimer’s disease and cerebral ischemia are among the many causative neurodegenerative diseases that lead to disabilities in the middle-aged and elderly population. There are no effective disease-preventing therapies for these pathologies. Recent in vitro and in vivo studies have revealed the TRPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Prikhodko, Veronika, Chernyuk, Daria, Sysoev, Yurii, Zernov, Nikita, Okovityi, Sergey, Popugaeva, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692306/
https://www.ncbi.nlm.nih.gov/pubmed/33114455
http://dx.doi.org/10.3390/cells9112351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692306/
https://www.ncbi.nlm.nih.gov/pubmed/33114455
http://dx.doi.org/10.3390/cells9112351

Ejemplares similares